Diseases, Conditions, Syndromes

A roadmap for the future of hepatitis B therapy development

Worldwide, 880,000 people die each year as a result of infection with the hepatitis B virus (HBV). Antiviral drugs that can suppress replication of the virus are available. However, these must be taken for decades, as there ...

Diseases, Conditions, Syndromes

Will new drugs block hepatitis C virus in its tracks?

Targeted multi-drug treatments for hepatitis C patients that could stop the virus in its tracks have come a step closer, thanks to researchers at the University of Leeds, UK.

Diseases, Conditions, Syndromes

Hepatitis B virus reemerges with long-term nucleoside analog treatment

A recently published study revealed that virological breakthrough (VBT) is common in patients receiving nucleoside analogs (NUCs) for chronic hepatitis B. Nearly 40% of the VBTs found were not related to antiviral drug resistance. ...

Diseases, Conditions, Syndromes

Explainer: What is a virus?

It may seem like a fairly fundamental question, but there is still debate over whether viruses should be considered a form of life.

page 19 from 40